Zobrazeno 1 - 8
of 8
pro vyhledávání: '"M H, Tavella"'
Publikováno v:
Acta Haematologica. 87:145-147
Clinical, laboratory features and restriction enzyme DNA analysis are reported for a black Brazilian woman with HbH disease. The patient presented a thalassemic blood picture with HbH and Hb Bart’s. G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c9c7b66aaff757aa49a5d82e1c5e405
https://doi.org/10.1159/000204741
https://doi.org/10.1159/000204741
Autor:
M A, Zago, W A, Silva, B, Dalle, S, Gualandro, M H, Hutz, C, Lapoumeroulie, M H, Tavella, A G, Araujo, J E, Krieger, J, Elion, R, Krishnamoorthy
Publikováno v:
American journal of hematology. 63(2)
The majority of the chromosomes with the beta(S) gene have one of the five common haplotypes, designated as Benin, Bantu, Senegal, Cameroon, and Arab-Indian haplotypes. However, in every large series of sickle cell patients, 5-10% of the chromosomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a14010f5210bd451dc13115d5227de7a
https://pubmed.ncbi.nlm.nih.gov/10629573
https://pubmed.ncbi.nlm.nih.gov/10629573
Publikováno v:
Haematologica. 85(1)
Recent studies have suggested an association between a genetic variation in the coagulation factor XIII (FXIII Val34Leu) and decreased risk of vascular thrombosis.We investigated the frequency of the FXIII Val34Leu polymorphism in 150 consecutive, un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a2a9c04dd114f68e81164d69152af832
https://pubmed.ncbi.nlm.nih.gov/10629595
https://pubmed.ncbi.nlm.nih.gov/10629595
Autor:
R F, Franco, P H, Reitsma, D, Lourenço, F H, Maffei, V, Morelli, M H, Tavella, A G, Araújo, C E, Piccinato, M A, Zago
Publikováno v:
Thrombosis and haemostasis. 81(5)
A mutation in the factor XIII gene (FXIII Val34Leu) gene was recently reported to confer protection against myocardial infarction, but its relationship with venous thrombosis is unknown. In addition, a mutation in the 5'-untranslated region of the FX
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d90b0e8cd057524c8f3bdec8c2b37f9b
https://pubmed.ncbi.nlm.nih.gov/10365735
https://pubmed.ncbi.nlm.nih.gov/10365735
Autor:
R F, Franco, V, Morelli, D, Lourenço, F H, Maffei, M H, Tavella, C E, Piccinato, I A, Thomazini, M A, Zago
Publikováno v:
British journal of haematology. 105(2)
We assessed the effect of a recently described mutation in the MTHFR gene (1298 A --C) on the risk of deep venous thrombosis (DVT) by determining its prevalence in 190 patients with verified DVT and in age-, race- and gender-matched controls. MTHFR 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7a12217198d2b259ce86de73ecc4393b
https://pubmed.ncbi.nlm.nih.gov/10233437
https://pubmed.ncbi.nlm.nih.gov/10233437
Autor:
R F, Franco, F H, Maffei, D, Lourenço, V, Morelli, I A, Thomazini, C E, Piccinato, M H, Tavella, M A, Zago
Publikováno v:
British journal of haematology. 103(3)
We investigated the prevalence of two reported mutations of the factor V gene (factor V Arg306--Thr, or factor V Cambridge, and factor V Arg306--Gly) in 104 relatively young patients with verified venous thrombosis and in 208 age-, sex- and race-matc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1dd7a9fab9f1f25282c8e1ad4ea459f3
https://pubmed.ncbi.nlm.nih.gov/9858251
https://pubmed.ncbi.nlm.nih.gov/9858251
Publikováno v:
Acta haematologica. 87(3)
Clinical, laboratory features and restriction enzyme DNA analysis are reported for a black Brazilian woman with HbH disease. The patient presented a thalassemic blood picture with HbH and Hb Bart's. Gene mapping demonstrated the compound heterozygous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2996e9fbb34f731c18551dcfd123efd7
https://pubmed.ncbi.nlm.nih.gov/1642095
https://pubmed.ncbi.nlm.nih.gov/1642095
Publikováno v:
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 24(2)
1. The molecular abnormality of a patient with thalassemia intermedia was identified by DNA amplification (PCR) combined with the use of synthetic oligonucleotide probes. 2. The patient is a homozygote for the T----C substitution at position 6 of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::28cfa7e5c9a1413f6d420379ef99de09
https://pubmed.ncbi.nlm.nih.gov/1823228
https://pubmed.ncbi.nlm.nih.gov/1823228